bristol-myers glp-1 receptor agonist products Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Agonists: A Multidisciplinary Expert Consensus S-1/A
Description
The individual tolerability and severity of gastrointestinal symptoms at the beginning of therapy are heterogeneous (36)
GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis
If material is not included in the articles Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder
Stimulants Preclinical research has shown reductions in cocaine self-administration in animals, but these effects have so far not translated to humans
